# PET/CT Imaging Companion Study To ACTG A5314

> **NCT02312219** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 35 (actual)

## Conditions studied

- HIV
- Inflammation
- Atherosclerosis

## Interventions

- **DRUG:** Folic Acid
- **DRUG:** Placebo
- **DRUG:** Low Dose Methotrexate

## Key facts

- **NCT ID:** NCT02312219
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-12-08
- **Final completion:** 2016-12-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312219, "PET/CT Imaging Companion Study To ACTG A5314". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02312219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*